Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics | 2 | 2013 | 115 | 0.520 |
Why?
|
| Anesthesia | 2 | 2015 | 296 | 0.460 |
Why?
|
| Glioblastoma | 4 | 2017 | 1797 | 0.270 |
Why?
|
| Craniotomy | 2 | 2018 | 304 | 0.250 |
Why?
|
| Recovery of Function | 2 | 2018 | 703 | 0.230 |
Why?
|
| Neurosurgical Procedures | 3 | 2017 | 609 | 0.230 |
Why?
|
| Brain Neoplasms | 5 | 2018 | 4849 | 0.220 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 2 | 2013 | 169 | 0.200 |
Why?
|
| Proton Therapy | 3 | 2015 | 1577 | 0.180 |
Why?
|
| Hyperthermia, Induced | 2 | 2013 | 510 | 0.160 |
Why?
|
| Spinal Diseases | 1 | 2018 | 125 | 0.150 |
Why?
|
| Postoperative Period | 2 | 2018 | 665 | 0.150 |
Why?
|
| Hyperglycemia | 2 | 2017 | 333 | 0.150 |
Why?
|
| Analgesics, Opioid | 2 | 2018 | 1371 | 0.150 |
Why?
|
| Anesthesia, Inhalation | 1 | 2016 | 25 | 0.150 |
Why?
|
| Anesthetics, Local | 1 | 2018 | 163 | 0.140 |
Why?
|
| Isoflurane | 1 | 2016 | 67 | 0.140 |
Why?
|
| Anesthetics, Inhalation | 1 | 2016 | 62 | 0.140 |
Why?
|
| Perioperative Period | 1 | 2017 | 155 | 0.140 |
Why?
|
| Nerve Block | 1 | 2018 | 176 | 0.140 |
Why?
|
| Monitoring, Intraoperative | 1 | 2017 | 264 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2017 | 305 | 0.130 |
Why?
|
| Cisplatin | 2 | 2013 | 2432 | 0.130 |
Why?
|
| Length of Stay | 2 | 2018 | 1900 | 0.120 |
Why?
|
| Anesthesia, Intravenous | 1 | 2014 | 42 | 0.120 |
Why?
|
| Pain Management | 1 | 2018 | 668 | 0.110 |
Why?
|
| Desmoplastic Small Round Cell Tumor | 1 | 2013 | 86 | 0.110 |
Why?
|
| Neoplasms | 2 | 2014 | 15193 | 0.090 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2013 | 500 | 0.090 |
Why?
|
| Combined Modality Therapy | 4 | 2016 | 8865 | 0.090 |
Why?
|
| Radiometry | 1 | 2015 | 980 | 0.090 |
Why?
|
| Robotics | 1 | 2013 | 359 | 0.090 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 321 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 849 | 0.080 |
Why?
|
| Brachytherapy | 1 | 2013 | 977 | 0.070 |
Why?
|
| Retrospective Studies | 9 | 2018 | 37905 | 0.060 |
Why?
|
| Bradykinin | 1 | 2004 | 79 | 0.060 |
Why?
|
| Radiosurgery | 1 | 2013 | 1330 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2016 | 5542 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 6207 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2013 | 14289 | 0.050 |
Why?
|
| Sarcoma | 1 | 2012 | 1725 | 0.050 |
Why?
|
| Analgesics | 1 | 2004 | 390 | 0.050 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 2796 | 0.050 |
Why?
|
| Disease-Free Survival | 3 | 2018 | 10001 | 0.050 |
Why?
|
| Survival Analysis | 3 | 2017 | 9180 | 0.050 |
Why?
|
| Female | 12 | 2018 | 141928 | 0.050 |
Why?
|
| Male | 11 | 2018 | 123000 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2004 | 610 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 4298 | 0.040 |
Why?
|
| Humans | 13 | 2018 | 261506 | 0.040 |
Why?
|
| Middle Aged | 7 | 2018 | 86204 | 0.040 |
Why?
|
| Adult | 7 | 2018 | 77950 | 0.040 |
Why?
|
| Prognosis | 4 | 2017 | 21713 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4557 | 0.040 |
Why?
|
| Scalp | 1 | 2018 | 156 | 0.040 |
Why?
|
| Young Adult | 4 | 2018 | 21445 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2016 | 344 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 10035 | 0.030 |
Why?
|
| Aged | 5 | 2018 | 70117 | 0.030 |
Why?
|
| Adolescent | 4 | 2015 | 31252 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2014 | 16273 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 15862 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2012 | 192 | 0.030 |
Why?
|
| Induction Chemotherapy | 1 | 2015 | 669 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 2352 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 2315 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 2803 | 0.020 |
Why?
|
| Child | 3 | 2014 | 29154 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 14889 | 0.020 |
Why?
|
| Chemoradiotherapy | 1 | 2016 | 1946 | 0.020 |
Why?
|
| Recurrence | 1 | 2015 | 4758 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 4988 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3890 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 9244 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2004 | 112 | 0.020 |
Why?
|
| Foot | 1 | 2004 | 104 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 4844 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2004 | 281 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 5687 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2004 | 709 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2004 | 953 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12221 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 2063 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 13310 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 13658 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 4938 | 0.010 |
Why?
|
| Rats | 1 | 2004 | 6086 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 29902 | 0.010 |
Why?
|
| Animals | 1 | 2004 | 59536 | 0.000 |
Why?
|